Related Experiment Video
Updated: Jul 29, 2025
15:41
A Microfluidic Chip for the Versatile Chemical Analysis of Single Cells
Published on: October 15, 2013
15.0K
The latest advances in high content screening in microfluidic devices
Weiyu Liu1, Jingyu Wang1, Huibo Qi1
1MOE Key Laboratory of Bioorganic Phosphorus Chemistry & Chemical Biology, Department of Chemistry, Laboratory of Flexible Electronics Technology, Center for Synthetic and Systems Biology, Tsinghua University, Beijing, China.
Expert Opinion on Drug Discovery
|May 23, 2023
Summary
Microfluidic devices enhance high-content screening (HCS) for drug discovery, overcoming limitations of traditional plates. These advanced platforms reduce costs, boost throughput, and improve accuracy in screening applications.
Area of Science:
- Biotechnology
- Drug Discovery
- Microfluidics
Background:
- Traditional multi-well plates limit high-content screening (HCS) for drug discovery and synthetic biology.
- Microfluidic devices offer solutions to overcome these limitations in experimental cost, assay throughput, and accuracy.
Purpose of the Study:
- To review microfluidic devices for high-content screening in drug discovery.
- To highlight advancements in droplet, microarray, and organs-on-chip technologies.
Main Methods:
- Review of microfluidic technologies applied to HCS.
- Analysis of droplet, microarray, and organs-on-chip systems.
- Discussion of integration with stem cell and gene editing technologies.
Main Results:
- Microfluidic-based HCS demonstrates unique advantages over traditional methods.
- Significant advancements in HCS applicability and usage in drug discovery are driven by microfluidics.
- Integration with other biological technologies expands personalized screening models.
Conclusions:
- Microfluidic devices are revolutionizing HCS for drug discovery.
- Expect rapid developments and increased importance of microfluidic approaches in HCS.
- Microfluidics-based HCS will be crucial for personalized disease and drug screening.
